National Institute for Health and Clinical Excellence (NICE)
Shared decision making underpins good healthcare
Shared decision making between service users and healthcare professionals is an integral part of healthcare, says NICE, in new guideline recommendations published yesterday.
The new recommendations advise that shared decision making should be part of everyday practice across all healthcare settings. The guideline sets out ways for healthcare professionals to work with people using services to make decisions about their treatment and care, and to ensure this is best practice at an organisational level.
Shared decision making is a collaborative process that involves a person and their healthcare professional working together to reach a joint decision about care.
Prof Gillian Leng, NICE chief executive, yesterday said:
“We’re delighted to see this shared decision making guideline published and we hope it will help people using healthcare services feel more confident in discussing care and treatment options with their healthcare teams. These recommendations should help healthcare professionals to embed good practice in all their interactions with the people they are caring for and at an organisational level.
“We view these recommendations as underpinning the implementation of all NICE’s work, and it’s important that these recommendations are put into practice at all levels across the system to support patient care.”
The new guideline offers advice on how to engage people accessing care in the shared decision-making process through honest conversation and by providing information resources before, during, and after appointments. The use of posters and patient decision aid leaflets are recommended to help the process.
The guideline suggests that, where possible, organisations should consider appointing a patient director to support the embedding of shared decision making at the most senior levels of the organisation and to help ensure the voice of service users is heard.
The guideline also includes recommendations on organisational planning, training and healthcare delivery to help organisations improve staff awareness of the importance of patient involvement, and ensure they are willing and able to embed shared decision making in organisational culture and practices.
Alongside the shared decision making guideline, NICE has collaborated with NHS England and NHS Improvement to develop a standards framework to determine whether the quality of shared decision-making support tools, including patient decision aids, is sufficient. The framework is designed for people who use patient decision aids, whether they are patients or clinicians. It also includes a simple self-assessment tool for people who produce patient decision aids so that they can quality check their processes and products.
James Sanderson, Director of Personalised Care at NHS England and NHS Improvement, yesterday said:
“We very much welcome the new shared decision making guidelines and framework published today by NICE, which encourages this very important conversation between clinicians and the people they are supporting, so the patients we look after get the most appropriate and effective care.
“This is critical in giving people choice and control over their mental and physical health, as we have committed to in the Long Term Plan, ensuring better experiences for people using health services based on partnership, and is particularly important as we recover from the COVID-19 pandemic.”
In addition to this, as part of a package of resources to accompany the shared decision making guideline, NICE has collaborated with Keele University to develop a learning package, aimed at healthcare professionals, to help with implementing these recommendations.
Prof Katie Maddock, Head of Keele University's School of Pharmacy and Bioengineering, yesterday said:
"The School of Pharmacy and Bioengineering is delighted to have been able to share our expertise in both shared decision making and the delivery of online education with the specialists at NICE to develop this new learning package. This new resource will enable practitioners from all healthcare professions to develop and put into practise the skills required for shared decision making which is a fundamental component of person-centred care. We are very much looking forward to the release of the education package alongside the new NICE guideline and also to evaluating its use within healthcare."
Prof Leng added:
“We’ve been delighted to collaborate with our partners to develop this guideline, the patient decision aid framework, and the learning package to fully support bringing these recommendations to the healthcare system.”
The guideline and accompanying tools and resources can be read here.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Update on the NICE ME/CFS guideline roundtable discussion22/09/2021 09:10:00
The roundtable meeting to discuss the updated guideline on the diagnosis and management of ME/CFS will be held on October 18th in London. It is being convened after publication of the guideline was paused when issues were raised by some professional groups during the pre-publication period
NICE and PHE recommend all employers give mental health training for managers17/09/2021 11:10:00
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
NICE recommends treatment for people with juvenile idiopathic arthritis10/09/2021 11:15:00
NICE yesterday (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
Professor Gillian Leng to retire from NICE09/09/2021 14:15:00
Professor Leng has spent more than 20 years working at NICE.
NICE draft guidance recommends apalutamide for treating prostate cancer08/09/2021 12:20:00
NICE has today (8 September 2021) published final draft guidance which now recommends apalutamide (also called Erleada and made by Janssen) plus androgen deprivation therapy for treating prostate cancer in adults
Sharing evidence with NICE is part of a broader approach to help Cochrane to identify priority reviews02/09/2021 11:15:00
Toby Lasserson, deputy editor in chief at Cochrane, writes about a new collaborative agreement with NICE, how it will work and what it means for the health service.
NICE approves ground-breaking cholesterol-lowering drug inclisiran01/09/2021 13:05:00
NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke
NICE and Cochrane sign collaborative agreement to deliver ‘living’ guideline recommendations01/09/2021 12:05:00
NICE and Cochrane have today (01st September 2021) signed a collaborative agreement which will help to deliver ‘living’ recommendations across the NICE guideline portfolio.
NICE announces next steps for ME/CFS guideline31/08/2021 09:15:00
NICE recognises the importance to patients of the updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) and is keen to move forwards as quickly as possible.